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ABSTRACT
We identified a human orthologue of tRNA:m
5C
methyltransferase from Saccharomyces cerevisiae,
which has been previously shown to catalyse the
specific modification of C34 in the intron-containing
yeast pre-tRNA
Leu
ðCAAÞ. Using transcripts of intron-less
and intron-containing human tRNA
Leu
ðCAAÞ genes as
substrates, we have shown that m
5C34 is introduced
only in the intron-containing tRNA precursors
when the substrates were incubated in the HeLa
extract. m
5C34 formation depends on the nucleotide
sequence surrounding the wobble cytidine and on
the structure of the prolongated anticodon stem.
Expression of the human Trm4 (hTrm4) cDNA in
yeast partially complements the lack of the endoge-
nous Trm4p enzyme. The yeast extract prepared
from the strain deprived of the endogenous TRM4
gene and transformed with hTrm4 cDNA exhibits
the same activity and substrate specificity toward
human pre-tRNA
Leu transcripts as the HeLa extract.
The hTrm4 MTase has a much narrower specificity
against the yeast substrates than its yeast ortho-
logue: human enzyme is not able to form m
5C
at positions 48 and 49 of human and yeast tRNA
precursors. To our knowledge, this is the first
report showing intron-dependent methylation of
human pre-tRNA
Leu
ðCAAÞ and identification of human
gene encoding tRNA methylase responsible for this
reaction.
INTRODUCTION
Maturation of eukaryotic cytoplasmic tRNAs is a multistage
process that includes the processing of 50 and 30 ends, intron
splicing in the case of intron-containing pre-tRNAs, transport
from the nucleus to the cytoplasm and numerous nucleoside
modiﬁcations that take place both in the nucleus and in
the cytoplasm. Three classes of intron-containing tRNA
genes are present in the human nuclear genome: tRNA
Tyr
ðGYAÞ
(8 genes with intron lengths ranging from 16 to 21 bp),
tRNALeu
ðm5CAAÞ (5 genes with intron lengths ranging from
22 to 25 bp) and tRNA
Arg
ðUCUÞ (1 gene containing a 15 bp
intron) (Genomic tRNA database, http://lowelab.ucsc.edu/
GtRNAdb). In all cases, introns are located one nucleotide
downstream from the anticodon, which is a typical feature
of nuclear intron-containing tRNA genes.
In the case of tRNA
Tyr
ðGYAÞ genes, it has been shown that the
introduction of pseudouridine in the middle position of the
anticodon (Y35) is intron dependent in yeast, plants, animals
and humans (1–3). Moreover, it has been demonstrated that
the introduction of Y35 strictly depends on the nucleotide
sequence surrounding the U35 to be modiﬁed and depends
rather on the length of the intron than on its structure
(4). Transfer RNALeu
ðCAAÞ genes contain introns in yeast
and vertebrates (5,6). However, in plants, there are no introns
in these genes (7). The ﬁrst position of the yeast anti-
codon sequence—cytosine—in tRNALeu
ðCAAÞ is methylated to
5-methylcytosine (m
5C)34. In yeast, this methylation is intron
dependent and its introduction strictly depends on the intron
structure (5).
The ﬁrst functional evidence of the importance of Y35 in
tRNA
Tyr and m
5C34 in tRNA
Leu came from the Abelson
laboratory (1,5). The construction of mutant yeast tRNA
Tyr
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Leu genes without introns resulted in the production
of mature tRNA molecules without appropriate modiﬁed
bases. When the suppressor activity of a tRNA
Tyr product
derived from intron-containing tRNA (SUP 6 coding for
ochre suppressor tRNA) with the ochre suppressor tRNA
transcribed from the gene without intron was compared,
it turned out that tRNA
Tyr derived from the mutated gene
without intron exhibited a strong reduction in the suppressor
activity. In an analogous experiment, a mutant, intron-less
yeast tRNA
Leu gene encoding amber suppressor tRNA
(SUP 53) also gave a product with a weak suppressor activity
when compared with the intron-containing amber tRNA
Leu
suppressor gene product. In both cases, the decreased
suppressor activity correlated with the absence of Y35
and m
5C34, respectively. Similarly, Y35 is required in the
anticodon (GYA) of cytoplasmic tRNA
Tyr from Nicotiana
rustica for UAG and UAA suppression in the translation of
the tobacco mosaic virus (TMV) RNA (8). Summarizing
the afore-mentioned experiments, it is clear that both Y35
and m
5C34 are necessary to stabilize anticodon–codon pairing
leading to the correct decoding of mRNA. In this paper, we
show that intron in the human pre-tRNALeu
ðCAAÞ is indispens-
able for the C5-methylation of cytosine in the ﬁrst position
of the anticodon. We also show that the modiﬁcation of C34
depends on the nucleotide sequence surrounding the position
to be modiﬁed and on the structure of intron-containing pro-
longated anticodon stem.
Enzymes that introduce Y35 and m
5C34 in the intron-
containing pre-tRNA
Tyr and pre-tRNA
Leu, respectively,
have been identiﬁed in yeast (9,10). However, our knowledge
about the corresponding enzymes in multicellular eukaryotes
remains obscure. The ﬁrst human m
5C methylase Dnmt2 has
been reported very recently and is responsible for the modi-
ﬁcation of C38 in tRNA
Asp in mice, Drosophila melanogaster
and Arabidopsis thaliana. This MTase was found to be local-
ized in cytoplasm and acts at the level of a mature tRNA
molecule (11). Here, we present the characterization of a
human gene encoding a methyltransferase (MTase) that is
involved in the formation of m
5C34 in tRNALeu
ðCAAÞ. The
product of the gene, hTrm4, acts at the level of the intron-
containing tRNA precursor and is localized in the nucleo-
plasm and nucleolus. During the preparation of this paper,
it was found that this MTase is a novel downstream Myc-
target which mediates Myc-induced cell proliferation and
growth. Therefore, the characterization of hTrm4 substrate
speciﬁcity can be essential since this MTase is a potential
target for cancer therapies (12).
MATERIALS AND METHODS
Enzymes and reagents
The restriction enzymes, T4 DNA polymerase and T4 DNA
ligase were from Roche, Fermentas and Promega. RNase
T2 and SAM (S-adenosyl-L-methionine) were obtained from
Sigma. [a-
32P]NTPs were from Amersham/Pharmacia Bio-
tech. Taq polymerase, T7 RNA polymerase, Calf Intestine
Alkaline Phosphatase (CIAP), dNTPs and NTPs were from
Fermentas. P1 nuclease was obtained from Roche. Marathon-
Ready cDNA library was obtained from the Clontech,
TAKARA BIO company. DNA sequencing was carried out
using fmol DNA Cycle Sequencing System from Promega
and CEQ DTCS Quick Start Kit from Beckman Coulter.
Oligonucleotides for ampliﬁcation and mutagenesis were
synthesized by oligo.pl. Cellulose plates for TLC were
purchased from Merck. Kits for plasmid isolation and for
DNA isolation from agarose were obtained from A&A
Biotechnology. The QuickChange Site-Directed Mutagenesis
Kit was from Stratagene. All other reagents were from
Amersham/Pharmacia Biotech, Fermentas and Sigma.
Bacterial, yeast and HeLa strains and plasmids
Escherichia coli TG1, CJ236 and JM109 were used as hosts
for the propagation of pUC19 plasmid and M13mp19 phage
derivatives, respectively. The recombinant plasmids used in
this study were: pHLIVS2 carrying the human tRNALeu
ðCAAÞ
gene and pYLIVS carrying the yeast tRNALeu
ðCAAÞ gene, respec-
tively. Both tRNA genes were inserted under T7 RNA poly-
merase promoter and contained the MvaI restriction site
to linearize plasmids and terminate the in vitro transcrip-
tion. Human HeLa cells were used for nuclear cell-free
extract preparations. Saccharomyces cerevisiae haploid strain
BY4742 (wild type) and its deletion derivative with the open
reading frame YBL024w (corresponding to the TRM4 gene)
replaced by kanMX4, a kanamycin resistance gene mediating
G418 resistance, were obtained from EUROSCARF. Yeast
strains were used for transformation and tRNA:m
5C methyl-
transferase activity assays. pYES2 (Invitrogen) vector was
utilized for protein expression in yeast.
Construction of tRNA
Leu gene mutants
The recombinant plasmid pHLIVS2 harbouring human
tRNA
Leu gene that contains the 22 bp intron was mutagenized
using the Kunkel method (13) or QuickChange Site-Directed
Mutagenesis Kit according to the manufacturer’s instructions.
The introduced mutations were conﬁrmed by DNA sequenc-
ing. The mini-helix consisting of the prolongated anticodon
stem of tRNALeu
CAA gene was synthesized according to the
Milligan’s method (14) with modiﬁcations described in
ref. (15) using two DNA oligonucleotides: one (58 nt long)
including the 17 nt long sequence of T7 RNA polymerase
promoter followed by the coding sequence of prolongated
anticodon stem containing 22 nt long intron and the other
with the sequence complementary to the T7 RNA promoter.
T7 RNA transcription of pre-tRNA(CAA)
Leu gene and its
mutants
Plasmids carrying the yeast tRNA
Leu gene and the human
tRNALeu
ðCAAÞ gene or its mutants (with the exception of mutant
pHLIVS2 C35) were linearized by digestion with MvaI before
transcription. Plasmid pHLIVS2 C35 contains a mutation
that introduces a new MvaI restriction site into the tRNA
Leu
mutant gene and was linearized with BamHI. In vitro
transcription was carried out in Fermentas T7 RNA poly-
merase buffer, 500 mM each of CTP, GTP, UTP, 12 mM
ATP, 50 mCi of [a-
32P]ATP, 1 mg of linearized plasmid
and 20 U of T7 RNA polymerase in total volume of 20 ml
at 37 C for 1.5 h. Radiolabelled ATP was added in the case
of the wild-type gene and all the mutant transcription reac-
tions with the exception of pHLIVS2 C35, pHLIVS2 G35
and pHLIVS2 C35 where [a-
32P]CTP, [a-
32P]GTP or
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32P]UTP were added, respectively. For the visualization
of m
5C localized at position 48/49 in tRNAs plasmids carry-
ing the yeast tRNA
Asp
ðGUCÞ, tRNASer
ðAGAÞ and the human
tRNALeu
ðCAAÞ genes were transcribed using [a-
32P]GTP. Tran-
scripts were puriﬁed on 10% denaturating polyacrylamide
gels, identiﬁed by autoradiography, excised from the gels
and eluted with 0.3 M sodium acetate (pH 5.2), 0.5 M
EDTA, 0.1% (w/w) SDS. After phenol/chloroform
extraction and ethanol precipitation, the RNA was resus-
pended in water. The average amount of the recovered
labelled tRNA transcripts varied between 1 and 2 pmol per
reaction. The transcription of mini-helix was performed as
described in (14,15).
In vitro 5-methylcytosine formation assays in
HeLa and yeast extract
A nuclear cell-free extract was prepared from HeLa cells
according to Dignam et al. (16). Yeast cells used for protein
extract preparations were grown as follows: single yeast
colony was picked from YPD agar plate and inoculated into
15 ml SD-U synthetic medium containing 0.67% nitrogen
base, 2% glucose, amino acids and no uracil. The culture
was grown overnight at 30 C with shaking. The OD600 of
the overnight culture was determined and the amount of cul-
ture necessary to obtain an OD600 of 0.4 in 50 ml of induction
medium was calculated and taken for further experiments.
Cells were pelleted at 1500 g for 5 min at 4 C, resuspended
in 2 ml of induction medium (SD-U medium containing 2%
galactose instead of 2% glucose), inoculated into 50 ml of the
induction medium and grown overnight at 30 C with shaking.
Yeast S-10 extract was prepared by the following procedure:
5 ml of cell suspension were centrifuged, collected, washed
twice in 500 ml of distilled water and resuspended in twice
their volume of lysis buffer [50 mM Tris–HCl, pH 7.5,
100 mM KCl, 0.1 mM EDTA, 10 mM MgCl2, 10% glycerol,
2% Protease Inhibitor Cocktail for yeast (Sigma)]. One vol-
ume of glass beads was added. The mixture was frozen in
liquid nitrogen and thawed at room temperature. The suspen-
sion was vigorously vortexed 5–7 times for 1 min with 5 min
pause between each vortexing when the suspension was kept
on ice. The resulting homogenate was centrifuged at 12 000 g
for 20 min to remove cell debris. The resulting supernatant
was aliquoted, quickly frozen in liquid nitrogen and kept
frozen at  70 C for later use.
Quantification of m
5C34 in pre-tRNA(CAA)
Leu
About 3000 c.p.m. of
32P-labelled RNAs, obtained as
described above, were digested with 0.5 U of RNase T2
for 5 h at 37 Ci n1 0ml of 5 mM ammonium acetate,
pH 4.6. The labelled nucleotides were identiﬁed by a two-
dimensional (2D) chromatographic analysis on cellulose
TLC plates as described by Grosjean et al. (17). The efﬁci-
ency of m
5C34 formation was measured by cutting out the
labelled spots from the TLC plates and counting the radio-
activity by the liquid scintillation technique. Otherwise,
radioactivity in the spots was evaluated by ImageQuant
5.1 software after exposure to a PhosphorImager screen
(Typhoon, Molecular Dynamics, USA) and scanning. Taking
into account the amount of label in each of the nucleotide
spots (AMP, UMP, GMP, CMP and/or m
5CMP) and knowing
the relative number of labelled nucleotides per RNA sub-
strate, the number of moles of m
5C per mole of pre-tRNA
was easily calculated.
Cloning of yeast and human TRM4 cDNA
Yeast Trm4 protein was used as a query in searching for
sequences of homologous proteins in the human expressed
sequence tags (ESTs) database using tBLASTn (18).
For the localization of the gene in human genome and the
determination of the chromosomal localization, BLAT soft-
ware was used.
hTrm4 cDNA was ampliﬁed from the human cDNA library
using following primers: 50-ATGGTGGTCAACCATGAT-
GCCTCCAGCATAC-30 and 50-TCACCGGGGTGGATGG-
ACCCCCGCCGG-30. PCR was performed in two step
‘touchdown’ manner, with the following conditions: 30 s at
96 C, followed by 25 cycles of 5 s at 96 C and 4 min
at 72 C. The PCR product of expected size was excised
from the agarose gel and eluted. The cDNA product was
re-ampliﬁed with primers harbouring sequences for XbaI
and EcoRI restriction enzymes and cloned into the pUC-19
vector (giving hTRM4/pUC construct) and sequenced.
Yeast genomic DNA was isolated using QIAGEN Genomic
DNA kit according to manufacturer’s instructions. Primers
used for the ampliﬁcation of yeast Trm4p cDNA were: 50-
AAAGGATCCACCATGGCTAGAAGAAAGAATTTCAA-30
(Kozak translation initiation sequence is marked in italics,
start codon is underlined and the BamHI restriction site
is in boldface) and 50-AAAGAATTCTCAATTAGCAG-
CGCTAGGAG-30 (the stop codon is underlined and EcoRI
restriction sequence is in boldface). After ampliﬁcation,
a product of expected size was excised and eluted from
the EtBr/agarose gel. Yeast and human TRM4 cDNA were
cloned into pYES2 yeast expression vector (constructs
TRM4/pYES2 and hTRM4/pYES2, respectively). After
each cloning procedure, the correctness of insert-vector
ligation was assessed by sequencing or restriction digestion.
Yeast cells transformation
Yeast strain DYBL024w was made competent by lithium
acetate/PEG 3350 treatment according to procedures
described in the User Manual for pYES2 vector system
(Invitrogen). Competent cells were then transformed by
puriﬁed pYES2 plasmid or its derivative constructs carrying
the sequence corresponding to the yeast TRM4 gene or
human TRM4 cDNA, respectively. Transformed yeast cells
were grown on a synthetic selective medium as required to
maintain plasmids.
Preparation of low-molecular weight RNA from
S.cerevisiae
Yeast RNA was extracted as described in (19). RNA products
were puriﬁed on 8% denaturing polyacrylamide gel. After
EtBr staining, bands corresponding to approximate tRNA
size (80–110 nt) were eluted from the gel, ethanol precipi-
tated, carefully washed with ethanol/water (70:30), resus-
pended in DEPC-treated water and kept frozen at  70 C
for later use.
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Low-molecular RNA (10–20 mg) was digested by P1 nucle-
ase according to the manufacturer’s manual (Roche).
Nucleotides were dephosphorylated by CIAP phosphatase.
The volume of the reaction was reduced to 10 ml by vacuum
centrifugation. HPLC separation was performed on the
reversed phase SUPELCOSIL  LC-318 HPLC Column, 25
cm · 4.6 mm (Supelco) attached to A ¨KTAexplorer 10S
(Amersham Pharmacia Biotech). Chromatographic solvents
were as follows: (A) 100 mM ammonium acetate and (B)
100% acetonitrile. HPLC conditions were: 4 C, 1 ml/min
ﬂow rate and absorbance measuring at l ¼ 277 nm.
The gradient method consisted of 2 CV (Column Volume)
solvent A, a gradient >10 CV to 6% solvent B, held 2 CV
solvent B and column re-equilibration. To determine reten-
tion times of standards, 10 ml mix of six ribonucleosides
(pseudouridine, cytidine, uridine, 5-methylcytidine, guano-
sine and adenosine), each at the concentration of 1 mM,
was separated.
RESULTS
m
5C34 in pre-tRNA(CAA)
Leu is formed only in
intron-containing precursors
Green et al. (20) isolated ﬁve tRNALeu
ðCAAÞ genes that slightly
differ in intron sequence. Inspection of the Genomic tRNA
database revealed that there are ﬁve human tRNALeu
ðCAAÞ
genes containing introns with nucleotide sequences identical
or nearly identical to those published by Green et al (20) and
Karwowska and Szweykowska-Kulinska (6).
The only human tRNALeu
ðC*AAÞ sequence with the identiﬁed
modiﬁed nucleosides is known from HeLa cells (21). Its
nucleotide sequence corresponds exactly to the nucleotide
sequence of the mature domain of the isolated human
tRNALeu
ðCAAÞ genes from HeLa cells with the exception of
one additional G nucleotide in the tRNA
Leu gene extra
arm coding sequence (6). However, Harada et al. (21) was
not able to identify the nature of modiﬁed cytidine in position
34. Storbel and Abelson (5) have shown that this modiﬁcation
in the yeast tRNA corresponds to m
5C and that its forma-
tion is intron-dependent. Using PCR, we have previously
isolated two intron-containing tRNALeu
ðCAAÞ genes from
human blood (6). One of the isolated human tRNALeu
ðCAAÞ
genes was studied further. It contains 22 bp intron. The puta-
tive structure of pre-tRNA
Leu derived from this gene is shown
in Figure 1a. The structure of the prolongated anticodon
stem containing intron is proposed according to the model
of yeast intron-containing pre-tRNALeu
ðCAAÞ (5). The putative
model of the extended anticodon stem shows that (i) the
second (A35) and third (A36) anticodon nucleotides and G37
can be base-paired with the complementary nucleotides of
the intron; (ii) the majority of the intron can be arranged in
two hairpin-stem and loop structures (arm I and arm II, see
Figure 1); (iii) the 50 splice site junction is located at the
boundary of the stem–loop of the ﬁrst arm in the prolongated
anticodon stem; (iv) the 30 splice site junction is located in
the unpaired region. To test whether C34 in human
pre-tRNALeu
ðCAAÞ is modiﬁed to m
5C and whether its introduc-
tion depends on the presence of 22 nt long intron, the
tRNA
Leu gene with the intron and a mutant of the tRNA
Leu
gene without (Figure 1b) were transcribed in vitro using
T7 RNA polymerase and [50-a
32P]ATP. Radiolabelled
transcripts were then incubated in the presence of nuclear,
cell-free HeLa extract which contained the activity necessary
for m
5C synthesis. The modiﬁed transcripts were gel-puriﬁed
and analysed for their m
5C content after a complete hydrol-
ysis of RNA with RNase T2. Since RNase T2 produces
nucleoside-30-monophosphates, the labelled phosphate is
exclusively derived from the nearest adenosine. This ensures
that only ﬁve cytidine nucleotides will be labelled in the
tRNA
Leu without intron and six in the intron-containing
precursor (Figure 1), since they have 30-ﬂanking adenosines.
The only m
5C that was found in the sequenced human
tRNALeu
ðCAAÞ was C48, but this nucleoside is accompanied at
the 30 side by guanosine and thus C48 is not labelled (21).
Nucleotides were resolved in a thin-layer two-dimensional
chromatographic system that separates modiﬁed nucleotides
from their unmodiﬁed counterparts. Figure 2 shows the
autoradiograms of T2 hydrolysates derived from intron-less
and intron-containing pre-tRNA
Leu. Only pre-tRNA contain-
ing intron gives rise to 30-m
5CMP (Figure 2a and b). It shows
that the only cytosine that can be methylated in the intron-
containing pre-tRNA
Leu is C34. Thus, the ﬁrst cytosine of
the anticodon of human pre-tRNALeu
ðCAAÞ is methylated in
intron-dependent manner.
The structure of a prolongated anticodon stem and
nucleotide sequence that surrounds the position to be
modified are crucial for m
5C34 formation in
pre-tRNA(CAA)
Leu
To learn more about the sequence and structure speciﬁcity of
m
5C34 methylation in tRNA
Leu precursor, a number of
mutants were generated where wild-type nucleotides occupy-
ing positions 32, 33, 35, 36 and 37 were exchanged for other
nucleotides. Moreover, two mutants were constructed with
partially deleted intron sequences (Figure 1c and d) and
four mutants in which either the base-pairing in the prolon-
gated anticodon stem was disrupted or base pairs were
reversed. All mutant pre-tRNAs listed in Table 1 were exam-
ined for their capacity to be substrates for m
5C34 formation
in HeLa cell-free nuclear extract.
A mini-helix consisting of prolongated anticodon stem was
not methylated at the C34 position. The removal of the intron
arm I or II resulted in the complete abolishment of C34
methylation. Thus, m
5C34 formation depends on the structure
of the intron-containing prolongated anticodon stem. The
exchange of C32 to A or U had no major effect on the efﬁci-
ency of m
5C34 formation (85% of the wild-type efﬁciency).
However, the exchange of C32 to G resulted in the inhibition
of m
5C34 methylation. The transversion of U33 to A did not
signiﬁcantly inﬂuence the formation of m
5C34. However,
the transversion of U33 to G and transition to C strongly
reduced the level of m
5C34 formation. All mutations in posi-
tions 35, 36 and 37 resulted in m
5C34-deﬁcient pre-tRNAs
Leu.
From these experiments, a consensus sequence for
m
5C34 methylation in pre-tRNA
Leu was established: C/A/
U32-U/A33-C34-A35-A36-G37. Careful inspection of the pro-
longated anticodon stem secondary structure reveals that
A35,A 36 and G37 can base pair with intron nucleotides
Ui11Ui10 and Ci9, respectively. To learn more about the
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5C34 methylation
within the prolongated anticodon stem, additional mutations
were introduced in which potential base pairs were reversed
or base-pairing was disrupted. The reversion of base pair
A35–Ui11 to U35–Ai11 did not promote m
5C34 formation.
The reversion of base pair A36–Ui10 to G36–Ci10 resulted in
85% efﬁciency of m
5C34 formation, showing that no A36
per se is indispensable for modiﬁcation but N36–Ni10 base-
pairing within the moiety of the prolongated anticodon stem
is crucial. However, like in the case of the base pair A35–Ui11,
the reversion of G37–Ci9 to C37–Gi9 resulted in a complete
abolishment of m
5C34 formation. In this case, not the base-
pairing but the identity of guanosine in position 37 (and
adenosine in the position 35), and possibly their pairing
with Ci9 and Ui10, respectively, is crucial for the modiﬁcation
to occur. Disruption of all three base pairs A36–Ui11,
A37–Ui10, and G37–Ci9 by the introduction of noncomplemen-
tary nucleotides within the intron sequence, i.e. Ai11,A i10
and Gi9, leads to the inhibition of m
5C34 formation. Thus,
both the sequence and structure of the prolongated
anticodon stem are crucial for the introduction of methyl
group on C34 of pre-tRNA
Leu.
Figure 1. Cloverleaf structure of tRNALeu
ðCAAÞ precursor containing intron (a), mature tRNA (b) and two mutants with partially deleted introns (derived from
plasmids pHLIVS2 DI1, pHLIVS2 DI2) (c and d). Anticodon sequence is underlined, arrows point to splice sites.
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The BLAST similarity search of human UniGene database at
NCBI (22) using the yeast Trm4p (enzyme that introduces
m
5C into yeast pre-tRNALeu
CAA in an intron-dependent manner)
as a query enabled us to identify EST sequences of a putative
human orthologue. The putative protein sequence encoded
by the contig sequence, constructed from identiﬁed ESTs
using the CAP3 program (23), shows 35% identity to the
yeast sequence. A comparison of the contig sequence with
the human genome revealed only one gene with an identical
putative coding sequence (NCBI accession no. NM_017755),
located on the human chromosome 5, with precise position
5p15.31. This gene is called NSUN according to HUGO
Gene Nomenclature Committee and contains 19 exons, and
encompasses  34 000 nt. Based on the results of the analyses
reported in this article, we propose to rename it as hTRM4.
Bioinformatic analysis of amino acid sequence of putative
m
5C34 MTases and the alignment of regions forming the
active site in yeast and human Trm4 enzymes were already
published by Bujnicki et al. (24). Sequence analysis using
the programs predictNLS (25), SignalP (26) and PSORT II
(http://psort.hgc.jp) revealed 60–70% probability of nuclear
localization of hTrm4. However, we did not ﬁnd any classical
nuclear localization signals (NLS) within the protein
sequence.
Using the cDNA library from HeLa cells, we isolated a
2304 bp cDNA encoding hTrm4 protein. Its nucleotide
sequence was conﬁrmed to be identical to the virtually
constructed cDNA contig from EST libraries and to exon
sequences of the identiﬁed human gene.
Human Trm4 catalyses the formation of m
5C34 in
human pre-tRNACAA
Leu
Since our efforts to overexpress the hTrm4 protein in
different prokaryotic expression systems were unsuccessful
(data not shown), we decided to investigate hTrm4 activity
in yeast strain BY4742 with the deleted endogenous TRM4
gene. The deletion of this gene has no phenotypic effect on
cell growth (27). Dtrm4 yeast strain BY4742 was transformed
with hTrm4 cDNA that was cloned into yeast pYES2
plasmid. The same yeast strain was also transformed with
pYES2 plasmid containing yeast Trm4p cDNA. Low-
molecular weight RNA was isolated from both yeast lines,
digested with P1 nuclease and digestion products were
dephosphorylated. Nucleosides were separated on HPLC
chromatography using RPC18 column. Figure 3 presents
the chromatographic elution proﬁles of nucleosides from
yeast lines: wild type, Dtrm4, Dtrm4 transformed with
plasmid carrying hTrm4 cDNA and Dtrm4 transformed with
plasmid carrying yeast Trm4p cDNA. In the elution proﬁle of
nucleosides obtained from low-molecular weight RNA from
Dtrm4 + yeast Trm4p, the level of m
5C was restored to that
achieved for m
5C for wild-type yeast strain. In the Dtrm4
yeast strain, m
5C nucleosides are undetectable. In the case
of Dtrm4 + hTrm4 cDNA, we observed only a low level of
m
5C. However, this small peak appeared repeatedly in all
consecutive experiments. The low level of m
5C methylation
may be due to several (mutually not exclusive) reasons:
(i) hTrm4 protein recognizes a small group of substrates
that are normally methylated by the yeast Trm4p enzyme,
(ii) the expressed hTrm4 enzyme has only residual activity,
e.g. because of non-native folding or post-translational
modiﬁcation or (iii) hTrm4 localization in yeast is not fully
correct. To test whether hTrm4 exhibits activity toward
human pre-tRNALeu
ðCAAÞ containing intron, we prepared total
protein extracts from Dtrm4, Dtrm4 + hTrm4 cDNA,
Dtrm4 + Trm4p cDNA and wild-type yeast lines, and con-
ducted activity tests similar to those in the HeLa cell-free
nuclear extract. Figure 4 shows the m
5C34 analyses of
Figure 2. Analysis of m
5C34 content in intron-less (a) and intron-containing
(b) human pre-tRNALeu
ðCAAÞ by two-dimensional thin layer chromatography.
Pre-tRNAs were incubated in the cell-free nuclear HeLa extract. tRNA
Leu
precursors were synthesized and treated as described in Materials and
Methods.
Table 1. Efficiency of C34 to m
5C34 conversion in HeLa extract
Mutant name Mutation site Relative amount of
m
5C34 (%)
pHLIVS2 wt 100
Mini-helix pre-tRNA
Leu anticodon
stem-containing intron
0 (undetectable)
pHLIVS2 D I Intron deleted 0
pHLIVS2 D I 1 Intron arm I deleted 0
pHLIVS2 DI 2 Intron arm II deleted 0
pHLIVS2 A32 C32 ! A32 85
pHLIVS2 G32 C32 ! G32 0
pHLIVS2 U32 C32 ! U32 85
pHLIVS2 A33 U33 ! A33 85
pHLIVS2 C33 U33 ! C33 10
pHLIVS2 G33 U33 ! G33 10
pHLIVS2 C35 A35 ! C35 0
pHLIVS2 G35 A35 ! G35 0
pHLIVS2 U35 A35 ! U35 0
pHLIVS2 C36 A36 ! C36 0
pHLIVS2 G36 A36 ! G36 0
pHLIVS2 U36 A36 ! U36 0
pHLIVS2 A37 G37 ! A37 0
pHLIVS2 C37 G37 ! C37 0
pHLIVS2 U35A11i A35 ! U35,U 11i ! A11i 0
pHLIVS2 U37 G37 ! U37 0
pHLIVS2 G36Ci10 A36 ! G36,U i10 ! Ci10 85
pHLIVS2 C37Gi9 G37 ! C37,C i9 ! Gi9 0
pHLIVS2 Gi9Ai10Ai11 Ci9 ! Gi9,U i10 ! Ai10,
Ui11 ! Ai11
0
32P-labelled pre-tRNAs
Leu were incubated in cell-free nuclear extract for
20 min at 30 C. The intron-containing pre-tRNA
Leu and its mutants were
analysed for the presence of m
5C34 after T2 digestion by thin layer
chromatography as described in Materials and Methods. The efficiency of
m
5C34 formation was calculated as described in Materials and Methods.
Nucleic Acids Research, 2006, Vol. 34, No. 20 6039human intron-less and intron-containing pre-tRNAsLeu
ðCAAÞ in
the wild-type yeast strain (Figure 4a), Dtrm4 (Figure 4b),
Dtrm4 + hTrm4 cDNA (Figure 4c) and Dtrm4 + Trm4p
cDNA yeast lines (Figure 4d). In the case of the wild-type
yeast strain, human pre-tRNA
Leu containing intron is a
substrate for endogenous MTase while pre-tRNA
Leu without
intron is not. When the protein extract from Dtrm4 yeast
line was used, there was no m
5C in intron-containing and
intron-less pre-tRNAs. However, when we used the protein
extract prepared from Dtrm4 + Trm4p cDNA, human intron-
containing pre-tRNA
Leu was methylated at C34, demon-
strating that in the wild-type yeast strain TRM4 MTase
was responsible for m
5C34 formation. In the case of Dtrm4
+ hTrm4 cDNA, human pre-tRNALeu
ðCAAÞ was methylated
when its precursor contained an intron. Finally, yeast
pre-tRNALeu
ðCAAÞ containing intron is methylated at C34 in the
S-10 yeast extract prepared from the Dtrm4 + hTrm4 strain
(Figure 4e). Figure 5 shows the kinetics of m
5C34 formation
in human intron-containing pre-tRNALeu
ðCAAÞ in the extract
prepared from the Dtrm4 + hTrm4 cDNA yeast line. The efﬁ-
ciency of m
5C34 formation in yeast pre-tRNA
Leu in the same
yeast line is about the same ( 45%, data not shown). Several
mutants of the human pre-tRNALeu
ðCAAÞ were tested in yeast
extracts containing the human Trm4 enzyme. In all cases,
we obtained similar results as in the case of HeLa cell-free
nuclear extract (data not shown). These biochemical experi-
ments deﬁnitely prove that the human gene identiﬁed by us
encodes a functional counterpart of the yeast Trm4p enzyme.
Human Trm4 has narrower substrate specificity than
its yeast orthologue
Apart from methylating C34 in yeast pre-tRNA
Leu containing
intron, yeast Trm4p is required for C48 and C49 methylation
Figure 4. Analysis of m
5C34 content in human pre-tRNALeu
ðCAAÞ without intron
and containing intron by 2-D thin layer chromatography. Pre-tRNAs were
incubated in yeast S-10 extract derived from wild-type strain (a), BY4742
DTRM4 (b), BY4742 DTRM4 transformed with pYES2-containing hTrm4
cDNA (c) and BY4742 DTRM4 transformed with pYES2-containing yeast
Trm4p cDNA (d). (e) Incubation of yeast pre-tRNALeu
ðCAAÞ containing intron in
S-10 extract prepared from BY4742 DTRM4 transformed with pYES2-
containing hTrm4 cDNA. tRNA
Leu precursors were synthesized and treated
as described in Materials and Methods.
Figure 3. Detection of m
5C in bulk low-molecular weight RNA extracted
from yeast wild-type strain BY4742 (b), BY4742 DTRM4 (c), BY4742
transformed with pYES2 containing yeast Trm4p cDNA (d) and BY4742
DTRM4 transformed with pYES2 containing hTrm4 cDNA (e). Separation of
a test nucleoside mixture (Y,U ,C ,m
5C, G and A) is presented in (a).
The total RNA fraction was completely hydrolysed by nuclease P1 and the
resulting nucleotides dephosphorylated by CIAP. Analysis of nucleosides was
performed as described in Materials and Methods.
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yeast lines described in the preceding chapter, we examined
hTrm4 ability to methylate cytosines at positions 48/49.
hTrm4 is not able to introduce a methyl group at position
C48 of human tRNA
Leu, both at the level of intron-containing
and intron-less precursors (Figure 6a), while the yeast Trm4p
methylates human intron-less precursor and does not recog-
nize intron-containing substrate (Figure 6b). Additionally,
we analysed m
5C48 and m
5C49 formation in yeast
tRNASer
ðAGAÞ and tRNA
Asp
ðGUCÞ, respectively. We show that
neither of them is methylated at C48 or C49 by hTrm4 and
both are substrates for yeast Trm4p (Figure 6c and d). Control
experiments carried out in the Dtrm4 strain show no detection
of m
5C48/49 formation in any tRNA tested (data not shown).
Thus, human Trm4 substrate speciﬁcity is narrower than in
the case of its yeast orthologue.
DISCUSSION
In this article, we describe the identiﬁcation, cloning and
enzyme activity of the corresponding gene product encoding
human Trm4 enzyme. This is the ﬁrst report showing intron-
dependent methylation of human pre-tRNALeu
ðCAAÞ and identi-
ﬁcation of human gene encoding tRNA methylase responsible
for this reaction. The hTRM4 gene was identiﬁed on the basis
of its amino acid sequence similarity to a known Trm4p
MTase from yeast. Our studies provide experimental valida-
tion of the phylogenetic analysis of RNA:m
5C MTases by
Bujnicki et al. who predicted the product of the NSUN2
gene as the closest human homologue of yeast Trm4p
(24). hTRM4 is a single-copy gene, located on the human
chromosome 5, with the precise position 5p15.31. The
hTrm4 protein is a member of an evolutionarily conserved
family, which includes genuine and putative RNA:m
5C
MTases from all three domains of life, such as the human
nucleolar proliferation-associated antigen p120 (NOL1) and
its homologues. Wu et al. (27) reported that the yeast
Trm4p was found to be localized in the nucleus, including
the nucleolus, and was concentrated at the nuclear periphery.
Our experiments have shown that its human homologue
hTrm4 is always localized in the nucleoplasm and in nucleoli
of HeLa cells, and in several cases we also observed a
concentration of hTrm4 at the nuclear periphery (data not
shown). These data have been recently conﬁrmed by Frye
and Watt (12).
The presence of an intron is required for the m
5C34 forma-
tion in human pre-tRNALeu
ðCAAÞ as demonstrated in this paper
by the maturation of intron-less and intron-containing tRNA
precursor in HeLa cell-free nuclear extract. In earlier studies,
Harada et al. (21) showed that this position in the mature
human tRNALeu
ðCAAÞ is occupied by a hypermodiﬁed derivative.
The authors suggest that this is a 20-O-methylated and further
hypermodiﬁed cytidine derivative (21). Very similar results
were obtained by Randerath et al. (28) when leucine
tRNAs were isolated and sequenced from rat tumour, Morris
hepatoma 5123D cells. Our studies show that the ﬁrst stage
of C34 modiﬁcation process in HeLa cells is the m
5C34
formation. However, the ﬁnal chemical structure of this
modiﬁcation remains to be characterized. In addition to
intron-dependent m
5C34 formation, we have shown that the
activity of hTrm4 strictly depends on a speciﬁc sequence
surrounding the cytosine to be modiﬁed and on the intron
structure. Similar results were obtained studying the yeast
Trm4p enzyme by Storbel and Abelson (5). However, our
experiments have shown that minisubstrate composed of the
anticodon stem–loop extended by the intron was not methy-
lated at C34. In contrast, Motorin and Grosjean (10) presented
data that analogous minihelix of yeast tRNALeu
ðCAAÞ was an
efﬁcient substrate for tRNA:m
5C-methyltransferase. These
results imply that there are differences in the ability of
enzyme–substrate recognition between the human and fungi
Trm4 enzymes. The nucleotide sequence that surrounds
C34 in human tRNA precursor is more restrictive for m
5C34
Figure 5. Kinetics of m
5C34 formation in human intron-containing pre-tRNALeu
ðCAAÞ.
32P-labelled pre-tRNA
Leu transcripts were incubated with S-10 yeast extract
prepared from BY4742 Dtrm4 + hTrm4 cDNA at 30 C for 10, 20, 40 and 90 min and analyzed for the relative amount of m
5C residues at position 34.
The measurements were taken as described in Materials and Methods.
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osine from the middle position of the anticodon to uridine did
not promote m
5C34 formation in human tRNA precursor
while in the case of yeast amber leucine-inserting pre-tRNA
containing intron (anticodon CUA), m
5C34 was formed.
Additionally, our experiments have shown that the reversion
of base pair A35–Ui11 to U35–Ai11 also resulted in the m
5C34
deﬁcient pre-tRNALeu
ðCAAÞ. Moreover, human MTase responsi-
ble for the introduction of methyl group at the anticodon
wooble cytosine (hTrm4) requires a consensus nucleotide
sequence C/A/U32-U/A33-C34-A35-A36-G37 as a prerequisite
for m
5C34 formation. Thus, all nucleotides from the anticodon
loop that are present upstream from the intron sequence are
essential for pre-tRNA
Leu modiﬁcation. These results again
strengthen the conclusion about the differences in the ability
of enzyme–substrate recognition between human and yeast
Trm4 enzymes.
Motorin and Grosjean showed (10) that the yeast Trm4p
enzyme catalysed m
5C formation at four distinct sites in dif-
ferent tRNAs: 34, 40, 48 and 49. m
5C was found at positions
34 and 40 only in two yeast tRNAs [tRNALeu
ðCUAÞ (Sup53) and
tRNAPhe
ðGAAÞ, respectively], whereas most elongator tRNAs
bore either m
5C48 or m
5C49, but never both in the same
tRNA molecule. Motorin and Grosjean concluded that yeast
Trm4p MTase is responsible for cytosine conversion in all
yeast tRNAs and pre-tRNAs, while two other identiﬁed
MTases encoded in S.cerevisiae genome are required for
proper rRNA m
5C modiﬁcation. We transformed yeast strain
BY4742 deprived of the TRM4 gene with yeast Trm4p cDNA
and human Trm4 cDNA. In the Dtrm4 + Trm4p cDNA strain,
the level of m
5C in low-molecular RNA molecules was
restored to that of the wild-type yeast strain (see Figure 3).
However, in the Dtrm4 + hTrm4 cDNA strain, the level
of m
5C was hardly detectable. It clearly shows that
human enzyme is not able to recognize the majority of
yeast tRNA substrates. Since our experiments show that
yeast and human Trm4 MTases both recognize mammalian
pre-tRNALeu
ðCAAÞ containing intron, the conclusion can be
drawn that the yeast enzyme has much broader substrate
speciﬁcity than the human Trm4. We conﬁrm this statement
showing that hTrm4 is not able to introduce m
5C48 at the
level of intron-containing and intron-less human pre-tRNA
Leu
precursor. Moreover, we show that it does not methylate
different yeast tRNA precursors at positions 48 and 49. In
the light of these observations, it is interesting to note that
Bujnicki et al. (24) identiﬁed two additional human putative
orthologues of yeast Trm4p, which have probably originated
from duplications and subsequent functional specializations
of the original TRM4 gene in the animal lineage. One or
both of these so-far uncharacterized genes may be responsible
for some of the methylations carried out by the yeast Trm4p,
but not exhibited by its human counterpart. This speculation
can explain a very low level of m
5C in the Dtrm4 + hTrm4
strain. Summarizing our results concerning the hTrm4
enzyme, it can be concluded that the enzyme acts on intron-
containing tRNALeu
ðCAAÞ precursors, it is more sensitive to the
nucleotide sequence that surrounds the position to be modi-
ﬁed than its yeast homologue Trm4p and it is equally sensi-
tive to the anticodon prolongated, intron-containing structure.
Moreover, its sensitivity to substrate speciﬁcity is more
constrained than in the case of yeast homologue—Trm4p.
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